These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7688254

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical review of risperidone.
    Chouinard G, Arnott W.
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
    [Abstract] [Full Text] [Related]

  • 24. Response to clozapine as a predictor of risperidone response in schizophrenia.
    Mok H, Yatham LN.
    Am J Psychiatry; 1994 Sep; 151(9):1393-4. PubMed ID: 7520672
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Iloperidone: Does it have a meaningful place in therapy?
    Dopheide JA.
    Am J Health Syst Pharm; 2011 Feb 15; 68(4):297. PubMed ID: 21289322
    [No Abstract] [Full Text] [Related]

  • 27. Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics?
    Lacey RL, Preskorn SH, Jerkovich GS.
    Am J Psychiatry; 1995 Sep 15; 152(9):1401. PubMed ID: 7544546
    [No Abstract] [Full Text] [Related]

  • 28. Behavioral stimulation associated with risperidone initiation.
    Byerly MJ, Greer RA, Evans DL.
    Am J Psychiatry; 1995 Jul 15; 152(7):1096-7. PubMed ID: 7540799
    [No Abstract] [Full Text] [Related]

  • 29. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.
    Kopala L, Honer WG.
    Am J Psychiatry; 1994 Nov 15; 151(11):1714-5. PubMed ID: 7524373
    [No Abstract] [Full Text] [Related]

  • 30. Adverse reaction reporting and new antipsychotics.
    Kerwin R.
    Lancet; 1993 Dec 11; 342(8885):1440. PubMed ID: 7504153
    [No Abstract] [Full Text] [Related]

  • 31. Risperidone: clinical safety and efficacy in schizophrenia.
    Borison RL, Pathiraja AP, Diamond BI, Meibach RC.
    Psychopharmacol Bull; 1992 Dec 11; 28(2):213-8. PubMed ID: 1381102
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Risperidone.
    Post L.
    Hosp Community Psychiatry; 1994 Nov 11; 45(11):1147. PubMed ID: 7530683
    [No Abstract] [Full Text] [Related]

  • 34. Re: Hypomania associated with risperidone.
    O'Croinin F, Zibin T, Holt L.
    Can J Psychiatry; 1995 Feb 11; 40(1):51. PubMed ID: 7533054
    [No Abstract] [Full Text] [Related]

  • 35. New advances in the treatment of schizophrenia. Introduction.
    Potkin SG.
    J Clin Psychopharmacol; 2008 Apr 11; 28(2 Suppl 1):S1-3. PubMed ID: 18334907
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prospects for pharmacotherapy of schizophrenia.
    Pickar D.
    Lancet; 1995 Mar 04; 345(8949):557-62. PubMed ID: 7539875
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.